{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:34:10Z","timestamp":1791203650231,"version":"4.2.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.semcancer.2004.06.009","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T18:45:53Z","timestamp":1095187553000},"page":"453-471","source":"Crossref","is-referenced-by-count":242,"title":["Infectious agents and cancer: criteria for a causal relation"],"prefix":"10.1016","volume":"14","author":[{"given":"Joseph S.","family":"Pagano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Blaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Annick","family":"Buendia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blossom","family":"Damania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Raab-Traub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Roizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2004.06.009_BIB1","doi-asserted-by":"crossref","unstructured":"Rickinson A, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM, editors. Fields virology, 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2001. p. 2575\u2013627.","DOI":"10.1016\/S0168-1702(01)00436-1"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1749-6632.1987.tb36249.x","article-title":"Mechanism of activation and biological role of the c-myc oncogene in B-cell lymphomagenesis","volume":"511","author":"Dalla-Favera","year":"1987","journal-title":"Ann. N.Y. Acad. Sci"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB3","doi-asserted-by":"crossref","unstructured":"Raab-Traub N. Epstein-Barr virus and nasopharyngeal carcinoma. In: Goedert JJ, editor. Infectious causes of cancer: targets for intervention. Totowa, NJ: Humana; 2000. p. 93\u2013111.","DOI":"10.1385\/1-59259-024-1:93"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB4","first-page":"1355","article-title":"Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia","volume":"146","author":"Pathmanathan","year":"1995","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/(SICI)1097-0215(19970207)70:4<375::AID-IJC1>3.0.CO;2-T","article-title":"Epstein-Barr virus-associated Hodgkin\u2019s disease: epidemiologic characteristics in international data","volume":"70","author":"Glaser","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB6","doi-asserted-by":"crossref","unstructured":"de The\u2019 G. Epidemiology of Epstein-Barr virus and associated diseases. In: Roizman B, editor. The herpesviruses, vol. I. New York: Plenum Press; 1982. p. 25\u201387.","DOI":"10.1007\/978-1-4684-4163-5_2"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.2910170102","article-title":"Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma","volume":"17","author":"Henle","year":"1976","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM198903163201103","article-title":"Hodgkin\u2019s disease and Epstein-Barr virus. Altered antibody pattern before diagnosis","volume":"320","author":"Mueller","year":"1989","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/smvy.1996.0039","article-title":"Pathogenesis of Epstein-Barr virus and its associated malignancies","volume":"7","author":"Raab-Traub","year":"1996","journal-title":"Semin. Virol"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB10","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1128\/MCB.24.12.5089-5093.2004","article-title":"Tumor viruses and cell-signaling pathways: deubiquitination versus ubiquitination","volume":"24","author":"Shackleford","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0092-8674(86)90803-2","article-title":"The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation","volume":"47","author":"Raab-Traub","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB12","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1023\/A:1008496509406","article-title":"Treatment of relapsed Hodgkin\u2019s disease using EBV-specific cytotoxic T cells","volume":"9","author":"Rooney","year":"1998","journal-title":"Ann. Oncol"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","article-title":"Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation","volume":"345","author":"Rooney","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/newbio246140a0","article-title":"Human lymphoid cell transformation by Epstein-Barr virus","volume":"246","author":"Pope","year":"1995","journal-title":"Nat. New Biol"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB15","first-page":"552","article-title":"Identification of EBV-DNA in tumour cells of AIDS-related lymphomas by in situ hybridisation [letter]","volume":"1","author":"Hamilton-Dutoit","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/infdis\/160.4.589","article-title":"Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases","volume":"160","author":"Katz","year":"1989","journal-title":"J. Infect. Dis"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0092-8674(95)90489-1","article-title":"The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family","volume":"80","author":"Mosialos","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB18","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1128\/MCB.18.5.2835","article-title":"Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression","volume":"18","author":"Miller","year":"1998","journal-title":"Mol. Cell. Biol"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB19","first-page":"2133","article-title":"Epstein-Barr virus induces invasion and metastasis factors","volume":"23","author":"Wakisaka","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB20","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1128\/MCB.24.12.5223-5234.2004","article-title":"Epstein-Barr virus latent membrane protein-1 induces synthesis of hypoxia-inducible factor-l\u03b1","volume":"24","author":"Wakisaka","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/107999002753452700","article-title":"Structure and function of interferon regulatory factor 7","volume":"22","author":"Zhang","year":"2002","journal-title":"Interferon and Cytokine Res"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB22","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1073\/pnas.91.2.772","article-title":"An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking","volume":"91","author":"Miller","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1074-7613(01)00089-9","article-title":"Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR","volume":"14","author":"Dykstra","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB24","doi-asserted-by":"crossref","first-page":"10681","DOI":"10.1128\/JVI.74.22.10681-10689.2000","article-title":"Epstein Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt","volume":"74","author":"Scholle","year":"2000","journal-title":"J. Virol"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB25","doi-asserted-by":"crossref","first-page":"12276","DOI":"10.1128\/JVI.77.22.12276-12284.2003","article-title":"Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells","volume":"22","author":"Morrison","year":"2003","journal-title":"J. Virol"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB26","first-page":"1552","article-title":"Epstein-Barr virus activates \u03b2-catenin in type III latently infected B-lymphocyte lines: association with deubiquitinating enzymes","volume":"26","author":"Shackelford","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-4608(91)90035-S","article-title":"Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma","volume":"54","author":"Huang","year":"1991","journal-title":"Cancer Genet. Cytogenet"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB28","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/JVI.78.2.868-881.2004","article-title":"Potential selection of LMP1 variants in nasopharyngeal carcinoma","volume":"78","author":"Edwards","year":"2004","journal-title":"J. Virol"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB29","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJM200004063421407","article-title":"Kaposi\u2019s sarcoma","volume":"342","author":"Antman","year":"2000","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","article-title":"Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi\u2019s sarcoma-associated herpes virus","volume":"88","author":"Nador","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/CMR.15.3.439-464.2002","article-title":"Spectrum of Kaposi\u2019s sarcoma-associated herpesvirus, or human herpesvirus 8, diseases","volume":"15","author":"Ablashi","year":"2002","journal-title":"Clin. Microbiol. Rev"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1098\/rstb.2000.0778","article-title":"Epidemiology and pathogenesis of Kaposi\u2019s sarcoma-associated herpesvirus","volume":"356","author":"Boshoff","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev.micro.57.030502.090824","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?","volume":"57","author":"Moore","year":"2003","journal-title":"Annu. Rev. Microbiol"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB34","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.1128\/JVI.72.10.8143-8149.1998","article-title":"Persistent infection of Epstein-Barr virus-positive B lymphocytes by human herpesvirus 8","volume":"72","author":"Kliche","year":"1998","journal-title":"J. Virol"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB35","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/29093","article-title":"Transformation of primary human endothelial cells by Kaposi\u2019s sarcoma-associated herpesvirus","volume":"394","author":"Flore","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/CBB:40:3:305","article-title":"Modulation of cell signaling pathways by Kaposi\u2019s sarcoma-associated herpesvirus (KSHV\/HHV-8)","volume":"40","author":"Damania","year":"2004","journal-title":"Cell Biochem. Biophys"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB37","unstructured":"Damania B. Gammaherpesviruses of non-human primates. The human herpesviruses: biology, therapy and immunoprophylaxis. Cambridge University; 2004; in press."},{"key":"10.1016\/j.semcancer.2004.06.009_BIB38","doi-asserted-by":"crossref","unstructured":"Wang L, Wakisaka N, Tomlinson CC, DeWire S, Krall S, Pagano JS, et al. The Kaposi\u2019s sarcoma-associated herpesvirus (KSHV\/HHV8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res 2004; 64.","DOI":"10.1158\/0008-5472.CAN-03-2570"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB39","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1084\/jem.191.3.417","article-title":"Viral G protein-coupled receptor and Kaposi\u2019s sarcoma: a model of paracrine neoplasia?","volume":"191","author":"Cesarman","year":"2000","journal-title":"J. Exp. Med"},{"issue":"5","key":"10.1016\/j.semcancer.2004.06.009_BIB40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF02256109","article-title":"Human herpesvirus-8-encoded signalling ligands and receptors","volume":"10","author":"Nicholas","year":"2003","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB41","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1038\/sj.onc.1206554","article-title":"Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation","volume":"22","author":"Fehrmann","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB42","first-page":"342","article-title":"Papillomaviruses and cancer: from basic studies to clinical. Application","volume":"2","author":"Zur Hausen","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB43","first-page":"19","article-title":"Signaling pathways and polyomavirus oncoproteins: importance in malignant transformation","volume":"8","author":"White","year":"2004","journal-title":"Gene Ther. Mol. Biol"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB44","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1038\/sj.onc.1206559","article-title":"Human neurotropic polyomavirus, JCV, and its role in carcinogenesis","volume":"22","author":"Khalili","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB45","doi-asserted-by":"crossref","unstructured":"Del Valle L, Gordon J, Ferrante P, Khalili K. JC virus in experimental and clinical brain tumorigenesis. In: Khalili K, Stoner GL, editors. Human polyomaviruses: molecular and clinical perspectives. New York: Wiley-Liss Inc.; 2001. p. 409\u201330.","DOI":"10.1002\/0471221945.ch15"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB46","doi-asserted-by":"crossref","unstructured":"Corallini A, Tognon M, Negrini M, Barbanti-Brodano G. Evidence for BK virus as a human tumor virus. In: Khalili K, Stoner GL, editors. Human polyomaviruses: molecular and clinical perspectives. Wiley-Liss Inc., New York; 2001. p. 431\u201360.","DOI":"10.1002\/0471221945.ch16"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB47","doi-asserted-by":"crossref","unstructured":"Arrington AS, Butel JS. SV40 and human tumors. In: Khalili K, Stoner GL, editors. Human polyomaviruses: molecular and clinical perspectives. New York: Wiley-Liss Inc.; 2001. p. 461\u201389.","DOI":"10.1002\/0471221945.ch17"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB48","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1038\/sj.onc.1204936","article-title":"Transforming functions of simian virus 40","volume":"20","author":"Saenz-Robles","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB49","doi-asserted-by":"crossref","first-page":"10214","DOI":"10.1073\/pnas.170207097","article-title":"Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity","volume":"97","author":"Bocchetta","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB50","first-page":"6125","article-title":"Different susceptibility of human mesothelial cells to polyomavirus infection and malignant transformation","volume":"63","author":"Carbone","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB51","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1006\/viro.1995.1529","article-title":"Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors","volume":"212","author":"Lednicky","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB52","first-page":"6068","article-title":"Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells","volume":"59","author":"Waheed","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB53","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0959-8049(99)00291-9","article-title":"Viruses in human cancers","volume":"35","author":"Zur Hausen","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB54","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1128\/JVI.77.9.5039-5045.2003","article-title":"Simian virus 40 infection of humans","volume":"77","author":"Garcea","year":"2003","journal-title":"J. Virol"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB55","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","article-title":"Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan","volume":"2","author":"Beasley","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB56","first-page":"40","article-title":"Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association","volume":"24","author":"Szmuness","year":"1978","journal-title":"Prog. Med. Virol"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB57","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/aje\/kwg041","article-title":"Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan","volume":"157","author":"Sun","year":"2003","journal-title":"Am. J. Epidemiol"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB58","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0065-230X(08)60306-1","article-title":"Hepatitis B viruses and hepatocellular carcinoma","volume":"59","author":"Buendia","year":"1992","journal-title":"Adv. Cancer Res"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB59","doi-asserted-by":"crossref","first-page":"296","DOI":"10.7326\/0003-4819-132-4-200002150-00008","article-title":"Pathogenesis, natural history, treatment, and prevention of hepatitis C","volume":"132","author":"Liang","year":"2000","journal-title":"Ann. Intern. Med"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB60","unstructured":"Hollinger FB. Hepatitis B virus. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology, 3rd ed. Philadelphia: Lippincott-Raven; 1996. p. 2738\u2013808."},{"key":"10.1016\/j.semcancer.2004.06.009_BIB61","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0168-8278(98)80001-9","article-title":"Impact of HBV, HCV and GBV-C\/HGV on hepatocellular carcinomas in Europe: results of a European concerted action","volume":"29","author":"Brechot","year":"1998","journal-title":"J. Hepatol"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB62","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1002\/hep.1840360710","article-title":"Hepatocellular carcinoma and hepatitis C in the United State","volume":"36","author":"El-Serag","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB63","doi-asserted-by":"crossref","unstructured":"Br\u00e9chot C. Hepatitis C virus: molecular biology and genetic variability. In: Schmid R, editor. Acute and chronic liver diseases. Basel, Switzerland: Kluwer Academic Publishers; 1996. p. 35\u201357.","DOI":"10.1007\/BF02087872"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB64","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1084\/jem.188.2.341","article-title":"Immune pathogenesis of hepatocellular carcinoma","volume":"188","author":"Nakamoto","year":"1998","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB65","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0092-8674(89)90770-8","article-title":"Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice","volume":"59","author":"Chisari","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB66","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/351317a0","article-title":"HBx gene of hepatitis B virus induces liver cancer in transgenic mice","volume":"351","author":"Kim","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB67","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1126\/science.294.5550.2376","article-title":"Calcium signaling by HBx protein in hepatitis B virus DNA replication","volume":"294","author":"Bouchard","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB68","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/2053","article-title":"The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice","volume":"4","author":"Moriya","year":"1998","journal-title":"Nat. Med"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB69","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/gast.2002.31001","article-title":"Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus","volume":"122","author":"Lerat","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB70","first-page":"243","article-title":"Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis","volume":"7","author":"Matsubara","year":"1990","journal-title":"Mol. Biol. Med"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB71","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1038\/sj.onc.1206492","article-title":"Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene","volume":"22","author":"Paterlini-Brechot","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB72","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/347294a0","article-title":"Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours","volume":"347","author":"Fourel","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB73","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1053\/jhep.2002.36366","article-title":"Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China","volume":"36","author":"Ming","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB74","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1111\/j.1572-0241.2001.04054.x","article-title":"The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans","volume":"96","author":"El-Serag","year":"2002","journal-title":"Am. J. Gastroenterol"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB75","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1053\/gast.2001.24798","article-title":"Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis","volume":"120","author":"Laurent-Puig","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB76","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1172\/JCI20925","article-title":"Helicobacter pylor persistence: biology and disease","volume":"113","author":"Blaser","year":"2004","journal-title":"J. Clin. Investig"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB77","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.1080857","article-title":"Traces of human migration in Helicobacter pylori populations","volume":"299","author":"Falush","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB78","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrc703","article-title":"Helicobacter pylori and gastrointestinal tract adenocarcinomas","volume":"2","author":"Peek","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB79","doi-asserted-by":"crossref","unstructured":"Helicobacter Cancer Collaborative Group (36 authors). Gastric cancer and Helicobacter pylori: a combined analysis of twelve case-control studies nested within prospective cohorts. Gut 2001;49:347\u201353.","DOI":"10.1136\/gut.49.3.347"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB80","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0006-3495(99)77301-7","article-title":"Helicobacter pylori vacuolating toxin forms anion-selective channels in planar lipid bilayers: possible implications for the mechanism of cellular vacuolation","volume":"76","author":"Tombola","year":"1999","journal-title":"Biophys. J"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB81","first-page":"562","article-title":"Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk","volume":"55","author":"Blaser","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB82","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/jnci\/94.22.1680","article-title":"Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma","volume":"94","author":"Figueiredo","year":"2002","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB83","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1034\/j.1600-065X.2002.18520.x","article-title":"Human retroviruses after 20 years: a perspective from the past and prospects for their future control","volume":"185","author":"Gallo","year":"2002","journal-title":"Immunol. Rev"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB84","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1073\/pnas.70.11.3265","article-title":"DNA of Epstein-Barr virus detected in tissue of Burkitt\u2019s lymphoma and nasopharyngeal carcinoma","volume":"70","author":"Nonoyama","year":"1973","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB85","doi-asserted-by":"crossref","unstructured":"Pagano JS. The Epstein-Barr virus and malignancy: molecular evidence. In: Cold Spring Harbor symposium on quantitative biology: tumor viruses, vol. XXIX. New York: Cold Spring Harbor Laboratory, Cold Spring Harbor; 1975. p. 797\u2013805.","DOI":"10.1101\/SQB.1974.039.01.092"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB86","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJM197312272892604","article-title":"Absence of Epstein-Barr viral DNA in American Burkitt\u2019s lymphoma","volume":"289","author":"Pagano","year":"1973","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB87","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1093\/jnci\/56.4.701","article-title":"Epstein-Barr virus in an American patient with Burkitt\u2019s lymphoma: detection of viral genome in tumor tissue and establishment of a tumor-derived cell line","volume":"56","author":"Gravell","year":"1976","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB88","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/jnci\/94.24.1832","article-title":"Commentary: new associations of human papillomavirus, simian virus 40, and Epstein-Barr virus with human cancer","volume":"94","author":"Wong","year":"2002","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1016\/j.semcancer.2004.06.009_BIB89","unstructured":"Stratton K, et al. Immunization safety review SV40 contamination of polio vaccine and cancer. The National Academies Press; 2003."},{"key":"10.1016\/j.semcancer.2004.06.009_BIB90","doi-asserted-by":"crossref","unstructured":"Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855\u20139.","DOI":"10.1056\/NEJM199706263362602"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X04000525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X04000525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:33:22Z","timestamp":1585874002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X04000525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S1044579X04000525"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2004.06.009","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}